Assessment Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Sign: In combination with chemotherapy, with the treatment method of adult clients with locally recurrent unresectable or metastatic triple-negative breast cancer who have not been given prior chemotherapy for metastatic ailment and whose tumours Specific programmed mobile Los